Alteogen Inc. (196170.KQ) stock analysis

In our weekly check, Alteogen Inc. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 19 pass, warnings: 2, red flags: 3.

About Alteogen Inc.

Alteogen Inc. is a Healthcare company (Biotechnology) based in South Korea, listed on KOE as 196170.KQ.

What our checks show for 196170.KQ

Red flags

• Analysts expect the net margin to shrink by 28.4 points from today's 75.3%.
• The price swings a lot: 74% annual volatility. Expect large ups and downs.
• The stock has fallen as much as 77% from a peak. Would you have held through that?

Warning signs

• Operating cash flow is only 0.65x net profit: part of the reported profit does not arrive as cash.
• Thinly traded (about 486 thousand shares a day): buying and selling can move the price.

Strengths

• Net debt is only 0.2x a year of EBITDA: the balance sheet has room.
• Operating profit covers interest 8.8 times over.
• The net margin rose by 91.5 points over 5 years, to 75.3%.
• The gross margin is 87.8% and has risen by 50.1 points: pricing power is holding.
• Analysts expect earnings per share to grow about 49.5% a year over the next years.
• Analysts expect revenue to grow about 71.8% a year over the next years.

Next earnings report: 2026-11-12

Similar companies

068270.KS · 207940.KS

Questions

What grade does Alteogen Inc. (196170.KQ) have?

In our weekly check, Alteogen Inc. is graded B (A to F). Of 24 checks on debt, profit, cash flow and trend: 19 pass, warnings: 2, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 196170.KQ stock?

This week's biggest flags for Alteogen Inc.: Margins expected to shrink, Very volatile, Deep past fall. In total 5 of 24 checks show a warning or a red flag.

What does Alteogen Inc. do?

Alteogen Inc. is a Healthcare company (Biotechnology) based in South Korea, listed on KOE as 196170.KQ.

When does Alteogen Inc. report earnings next?

The next earnings report is expected on 2026-11-12. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis